Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Post by noodleyon Nov 10, 2010 10:47pm
494 Views
Post# 17690388

shareholder value/tbi

shareholder value/tbire tonight's nr - i was expecting something like this....but not something like THIS!  25 million..and 2 years.  can you say, gazillion shares outstanding????  how does that improve a key goal of "shareholder value"?

meantime....did anybody see the cbc bit on tbi and afganistan tonight?  the numbers in canada were aweful - 1000 plus.  but they talked to the head of the us military who looks after this.....american numbers were over a staggering 100,000.  and...the us military now makes testing for tbi mandatory for any soldier who's anywhere near a blast.  currently...no treatment. hummmmmm
Bullboard Posts